Name: Latest research reports of Biocon Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: Axis Direct

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

340.1500 1.25 (0.37%)

NSE Sep 29, 2025 15:31 PM

Volume: 1.7M

Biocon Ltd.

24 Jan 2022

340.15

0.37%

Result Update:Biocon

Buy: Biocon Ltd.

Target

Axis Direct

Therefore, we recommend a BUY rating with a Target Price of Rs 425, implying an upside of 14% from the CMP.

Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.